Simultaneous optimization of wet granulation process involving factor of drug content dependency on granule size

Drug Development and Industrial Pharmacy

Volumn 24, Issue 11, 1998, Pages 1055-1065

  Miyamoto, Yousuke ^a   Ryu, Akio ^a   Sugawara, Shinya ^a   Miyajima, Masaharu ^a   Ogawa, Shigeo ^a   Matsui, Masayuki ^a   Takayama, Kozo ^b   Nagai, Tsuneji ^b  

^a ZERIA PHARMACEUTICAL CO LTD   (Japan)

^b HOSHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; ETHENZAMIDE; HYDROXYPROPYLCELLULOSE; LACTOSE; MICROCRYSTALLINE CELLULOSE; STARCH;

ARTICLE; DRUG FORMULATION; DRUG GRANULE; DRUG MANUFACTURE; PARTICLE SIZE;

EID: 0031658734     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.3109/03639049809089949     Document Type: Article

References (24)

1. T. Schaefer, H. H. Bak, A. Jaegerskou, A. Kristensen, J. R. Svensson, P. Holm, and H. G. Kristensen, Pharm. Ind., 48, 1083 (1986).
2. P. Wehrle, Ph. Nobelis, A. Cuine, and A. Stamn, Drug Dev. Ind. Pharm., 19, 1993 (1993).
3. S. Aoki, A. Okamoto, M. Nemoto, T. Yoshida, K. Danjo, H. Sunada, and A. Otsuka, Yakuzaigaku, 53, 194 (1993) [in Japanese].
4. T. Schaefer, H. H. Bak, A. Jaegerskou, A. Kristensen, J. R. Svensson, P. Holm, and H. G. Kristensen, Pharm. Ind., 49, 297 (1987).
5. S. Ogawa, T. Kamijima, Y. Miyamoto, M. Miyajima, H. Sato, K. Takayama, and T. Nagai, J. Pharm. Sci., 83, 439 (1994).
6. O. Shirakura, M. Yamada, M. Hashimoto, S. Ishimaru, K. Takayama, and T. Nagai, Drug Dev. Ind. Pharm., 17, 471 (1991).
7. Y. Miyamoto, S. Ogawa, M. Miyajima, H. Sato, K. Takayama, and T. Nagai, Drug Dev. Ind. Pharm., 21, 2213 (1995).
8. Y. Miyamoto, S. Ogawa, M. Miyajima, M. Matsui, H. Sato, K. Takayama, and T. Nagai, Int. J. Pharm., 149, 25 (1997).
9. K. Terashita, M. Yasumoto, and K. Miyanami, Yakugaku Zasshi, 105, 1166 (1985) [in Japanese].
10. K. Terashita, A. Oh'ike, M. Kato, and K. Miyanami, Yakugaku Zasshi, 107, 377 (1987) [in Japanese].
11. P. Holm, T. Schaefer, and H. G. Kristensen, Powder Technol., 43, 225 (1985).
12. C. Fuhrer, Interparticulate affraction mechanisms, in: Pharmaceutical Powder Compaction Technology (G. Alderborn and C. Nystrom, eds.), Marcel Dekker, New York, 1996, p. 13.
13. K. Nishimura, T. Takeda, E. Yui, and M. Ikeda, Yakuzaigaku, 38, 117 (1978) [in Japanese].
14. K. Nishimura and E. Yui, Yakuzaigaku, 38, 124 (1978) [in Japanese].
15. K. Nishimura and E. Yui, Yakuzaigaku, 38, 131 (1978) [in Japanese].
16. F. Higashide, A. Miyagishima, and K. Ishibashi, Yakuzaigaku, 44, 268 (1984) [in Japanese].
17. T. Suzuki, K. Watanabe, S. Kikkawa, and H. Nakagami, Chem. Pharm. Bull., 42, 2315 (1994).
18. A. I. Khuri and J. A. Cornell, Response Surface - Designs and Analysis, Marcel Dekker, New York, 1987, pp. 105-148.
19. D. E. Fonner, Jr., J. R. Buck, and G. S. Banker, J. Pharm. Sci., 59, 1587 (1970).
20. G. Derringer and R. Suich, J. Quality Technol., 12, 214 (1980).
21. K. Takayama and T. Nagai, Chem. Pharm. Bull., 37, 160 (1989).
22. A. I. Khuri and M. Conlon, Technometrics, 23, 363 (1981).
23. K. Takayama and T. Nagai, Int. J. Pharm., 74, 115 (1991).
24. T. Haga, H. Takeuchi, and T. Okano, Quality, J. Soc. Qual. Control., 6, 35 (1976) [in Japanese].